BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2021 12:42:13 AM | Browse: 856 | Download: 1692
 |
Received |
|
2021-03-16 15:04 |
|
Peer-Review Started |
|
2021-03-16 15:23 |
|
First Decision by Editorial Office Director |
|
2021-05-01 16:09 |
|
Return for Revision |
|
2021-05-01 16:09 |
|
Revised |
|
2021-05-09 16:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-06-16 13:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-06-16 14:00 |
|
Articles in Press |
|
2021-06-16 14:00 |
|
Edit the Manuscript by Language Editor |
|
2021-06-26 02:45 |
|
Typeset the Manuscript |
|
2021-07-06 13:14 |
|
Publish the Manuscript Online |
|
2021-07-12 00:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Frontier |
| Article Title |
Liver dysfunction and SARS-CoV-2 infection
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abraham Edgar Gracia-Ramos, Joel Omar Jaquez-Quintana, Raúl Contreras-Omaña and Moises Auron |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abraham Edgar Gracia-Ramos, MD, MSc, N/A, N/A, Department of Internal Medicine, General Hospital, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P., Mexico City 02990, Mexico. dr.gracia.dmm@gmail.com |
| Key Words |
SARS-CoV-2; Coronavirus; COVID-19; Liver; Liver diseases; Liver failure; Liver injury; Cirrhosis |
| Core Tip |
Coronavirus disease 2019 (COVID-19)-associated liver injury is defined as any liver damage occurring during the disease course and treatment of COVID-19 in patients with or without pre-existing liver disease, with an observed ratio of 1:5. The presence of abnormal liver biochemical parameters has been associated with a severe course of severe acute respiratory syndrome coronavirus 2 infection and other complications, including death. Pathophysiology of COVID-19-induced liver injury is complex. Also, special consideration should be made in patients with pre-existing liver disease, such as metabolic dysfunction-associated fatty liver disease, chronic liver disease due to viral or autoimmune disease, liver transplant carriers, or cirrhosis. |
| Publish Date |
2021-07-12 00:42 |
| Citation |
Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i26/3951.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i26.3951 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
